We are pleased to announce the Europe Drug Discovery Summit, which will be held May 6-9, 2014 in Berlin, Germany. The summit is a forum for colleagues from industry and academia, as well as across multiple disciplines, to gather and share complementary perspectives on the latest research and breakthrough.

The summit includes four individual conferences that will take place over the course of the four days:
Cancer Drug Research & Development (May 6-7, 2014)
This conference will cover topics such as cancer targets, kinase inhibitors, drug resistance, combination therapy, cancer metabolism, invasion and metastasis, epigenetic regulators and immunotherapy.

Tissue Models & Drug Screening (May 6-7, 2014)
Physically relevant model systems have changed the way we look at early-stage drug discovery research. Come to learn about advances in HCA and phenotypic screening, using 3D models for target validation, and much more.

Drug Design & Medicinal Chemistry (May 8-9, 2014)
This meeting will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more.

Protein Kinases in Drug Discovery (May 8-9, 2014)
Leading experts will focus on drug discovery and design, novel drug targets, kinase inhibitor development, including cancer treatments, and lessons from pre-clinical models and clinical development for use in creating personalized therapies.
We hope you’ll be able to join us for exciting scientific presentations and dedicated networking sessions.